20241211 GLP-1 Agonist and Cardiovascular Disease: A Review of Recent Clinical Data
December 11, 2024
Learning Objectives
Upon completion of this activity, the participant should be able to:
- Review their evolution and current dosage forms for GLP-1
- Analyze information of CV benefits in clinical trials
- Accelerate adoption of GLP-1 use in patients with increased CV risk
BSWH-Irving
Irving, TX
United States
Available Credit
- 1.00 AMA PRA Category 1 Credit™The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 Attendance